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The Indian government has cut financial support for cancer research and treatment, despite the country facing the massive challenge of nearly one million new cancer cases every year. In the central government's annual budget for [2003] [2004] , allocation for the National Cancer Control Programme (NCCP) has been reduced to Rs 520 million from Rs 580 million.
NCCP provides grants to regional cancer centres and to two cancer centres in New Delhi and Kolkata. The money is used for detection and treatment activities such as installation of cobalt therapy units. Regional cancer centres are autonomous bodies run by respective state governments but Indian states also get funds for the development of oncology wings in government medical colleges. The NCCP official approached by The Lancet Oncology preferred to remain anonymous but did say that the cut "may be due to the fact that we were not able to absorb all the funds allotted to us in the past".
Jyotsna Govil of the Indian Cancer Society remarks: "this is a prime example of tokenism in matters of health. The allocation has been so meagre that a state like Delhi receives as little as Rs1·5 million per annum for hospitals run by the local administration."
Voluntary bodies who aim to increase awareness of cancer are also being given inadequate funds. Govil points out that "it is obvious the government has little use for a cancer education and prevention programme, despite every medical authority saying the incidence can be cut by 70% with screening and awareness programmes".
Experts say India needs rational budgeting for cancer programmes. At present, patients presenting with latestage disease, because of lack of awareness, prove to be a financial burden as scarce resources are used in their treatment without much outcome in terms of long-term survival.
"In addition to awareness and early detection, we need to spend money on treatment facilities to do away with long waiting lists. Otherwise, prematurely or early detected tumours will grow to become incurable and we will be helpless", says Manoj Sharma (LNJP Hospital, New Delhi). 
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The American Association for Cancer Research cancelled its annual meeting 3 days before it was due to begin in Toronto, Canada (April 5-9, 2003) because of the country's recent outbreak of Severe Acute Respiratory Syndrome (SARS).
"Cancelling the meeting was a difficult decision to make", says the organisation's Chief Executive Officer Margaret Foti (Philadelphia, PA, USA). The AACR received 6900 abstracts, booked 400 speakers, and expected about 16 000 participants to attend the meeting, Foti explains. The financial implications of cancelling the event are not yet known, but they could have a major effect on the AACR, she adds.
About 10 days before the conference, the AACR was concerned about the number of cancellations it was receiving from around the world, including some from speakers. "People were fearful of airborne transmission of the disease and being in close quarters with other participants from affected countries, including Canada", says Foti.
By April 10 Health Canada had reported 253 probable or suspected cases of SARS within the country. Ten people have died from the disease, and there have been 111 probable and 95 suspected cases in Ontario. All Canadian cases have occurred in people who have travelled to Asia or have had contact with SARS in the household or in a health-care setting.
The AACR contacted the World Health Organization, the US Centers for Disease Control and Prevention (CDC), and Toronto health officials, all of whom noted that there is not currently a concern about the widespread transmission of SARS to the community in Toronto.
Toronto's Medical Officer of Health, Sheela Basrur, wrote a letter to the AACR emphasising the precautions that health-care providers should take while attending the meeting but did not advise the organisation to cancel the conference, says a spokesperson from Toronto Public Health.
The CDC has not issued a formal recommendation regarding travel to Canada. The CDC recommends that individuals who are planning nonessential travel to mainland China, Hong Kong, Hanoi, Vietnam, or Singapore postpone their trip until further notice.
Based on this information, the AACR staff went to Toronto to prepare for the meeting. "However, we were still receiving cancellations", says Foti. Some cancer centres were advising their staff not to attend because of concerns about travelling to countries affected by SARS and the potential transmission of the disease from health-care professionals to their immunocompromised patients with cancer, she explains.
"We do however realise the importance of the meeting and are working hard to reschedule it", she adds.
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